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INTRODUCTION
Patient-controlled analgesia (PCA) is a well established
technique for providing pain control after surgery. PCA is
generally provided by high-technology microprocessor-con-
trolled infusion devices. A disposable device has been intro-
duced and evaluated clinically (1-5). However, many PCA
devices have been used without a single publication attest-
ing to their safety and accuracy, and certain adverse incidents
have led to calls for more rigorous testing (6, 7). The ratio-
nale for this study was to understand the general flow rate
patterns of the balloon elastomer infusor. We studied the
flow rate of two types of balloon infusors with somewhat
different shapes and composed of different materials (rubber
and silicone). Patients using these devices have reported that
infusion times are prolonged, sometimes up to twice of the
preset time as asserted by the manufacturers (8). Unfortu-
nately, most of the previous studies on the infusion rate of
the balloon-type infusor limited the observation period to
the maximum delivery time illustrated by the manufactur-
ers, so they could not show the flow rate pattern for the entire
delivery period of drug (9-12). We observed the flow rate of
the elastomeric balloon infusor during the entire drug delivery
with measurements of the internal pressure of the infusor.
MATERIALS AND METHODS
Two disposable elastomer balloon-powered units, the Ad-
vance Silicone Infusor (Wooyoung, Korea) and Baxter Two-
day Infusor (Baxter Health Corporation, U.S.A.) were used
in this study (Fig. 1). Both infusion devices are designed to
infuse drugs at a fixed rate (2 mL/hr) and have a maximum
capacity of 100 mL of analgesic solution. Twenty-one Ad-
vance Silicone Infusors (group I) and nineteen Baxter Two-
day Infusors (group II) were tested. After excluding the cases
that could not complete the study because of the technical
errors of the measurements and defects of the devices, the
data obtained from fifteen each of the two infusion devices
were analysed. There was one device in each group which
stopped delivery during experiments. The flow rates and
internal pressure of the infusors were measured as follows.
Measurement of the flow rate
The electronic balance was set at zero point after the infu-
sor was put on the electronic balance (Mettler PM 2000,
U.S.A.), and then the infusor was filled with normal saline
on the electronic balance until the total weight became 100
g. The tube was clamped when the normal saline was filled
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The Flow Rate of the Elastomeric Balloon Infusor is Influenced by
the Internal Pressure of the Infusor
The purpose of this study was to evaluate the flow rate of elastomeric balloon
infusor composed of rubber or silicone materials. Two models were studied: the
Baxter Twoday Infusor and Advance Silicone Infusor. Each infusion device has a
preset flow rate of 2 mL/hr. Fifteen units of each device were filled with 100 mL of
normal saline. The flow rate was measured gravimetically using an electronic bal-
ance. The internal pressure of the balloon infusor was measured with a Digital
pressure meter via the pressure transducer. The monitored internal pressure of
the two kinds of infusor was not maintained uniformly during the entire delivery
period, which was divided into 3 phases: the phase of decreasing, maintained,
and increasing pressure during the delivery of drug. Both devices initially infused
at a relatively high rate, followed by a somewhat steady flow rate. The flow rate
distinctly increased in the small residual volume. The flow rate of the balloon infu-
sor used in this study was not sustained uniformly during the entire delivery peri-
od and was in proportion to the internal pressure of the infusor regardless of the
materials.
Key Words : Elastomers; Infusion Pumps; Flow rateFlow Rates of the Elastomeric Balloon Infusor 703
up to the end of the delivery tube. The flow rate was deter-
mined by the change of the weight of infusor per unit time
after declamping of the delivery tube (Fig. 2). The experi-
ments ended when the residual weight of the infusor did not
change further. The room in which the experiments were
conducted was air-conditioned and maintained at a constant
room temperature. The results are expressed as mean±S.D.
Data were analyzed by one-way repeated measures analysis
of variance (ANOVA) followed by Dunnett’ s with the soft-
ware Sigma Stat. The significance level was set at p<0.05.
Measurement of the internal pressure of the infusor
The internal pressure of the balloon infusor was measured
with a Digital Pressure Meter 207
�(Dynatech Nevada Inc.,
U.S.A.) via the pressure transducer attached to the 16-gauze
needle inserted into the delivery tube of the infusor before
the Luer body which restricts the flow rate. Based on the
preliminary study, the internal pressure was repeatedly mea-
sured at every filling of the infusor with 2 mL of normal
saline until the weight of the infusor became 20 g. After
that, every 10 mL of normal saline was filled into the infu-
sor until a total of 80 mL of normal saline was filled within
the reservoir. Again, the internal pressure was measured at
every filling of 2 mL of normal saline until the total weight
became 100 g. This procedure was repeated vice versa dur-
ing the removal of the normal saline from the balloon infu-
sor filled with 100 mL of normal saline.
RESULTS
The internal pressure of the infusor
The internal pressure pattern of the infusor showed a hys-
teresis-like phenomenon during the process of filling and
emptying in the infusor with normal saline. However, we
evaluated the internal pressure of the infusor during the
decrease of the infusor volume because it could affect the
delivery of analgesic drug to the patient. When the drug
delivery began, the internal pressure of the infusor decreased
according to the decrease of the infusor volume. However,
the internal pressure sustained uniformly after the volume
A B
Fig. 1. (A) Advance Silicone Infusor; (B) Baxter Twoday Infusor.
Fig. 2. Diagram representing the experimental method. (A) Elec-
tronic balance (Mettler PM 2000, U.S.A.); (B) Infusor; (C) Beaker;
(D) Digital Pressure meter 207 (Dynatech Nevada Inc., U.S.A.).
The flow rate was determined by the change of the weight of
infusor hourly.
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of the infusor had reached to about 80 mL. The internal
pressure increased again when the infusor volume reached
to about 10 mL. This pressure pattern was observed both in
the group I and in the group II. The range of the internal
pressure of the group I was about 110-140 mmHg, and
that of the group II was about 380-450 mmHg during the
relatively uniform pressure state (Fig. 3).
Flow rate
We observed that the flow rate was related to the internal
pressure of the infusor. So the average flow rate was obtained
according to the infusor volume based on our preliminary
study about the internal pressure of the infusor and on the
data obtained in this study. The group I showed a flow rate
of 1.9 mL/hr, 1.6 mL/hr, and 2.2 mL/hr, corresponding to
the infusor volume of 100-80 mL, 80-10 mL, and 10-0 mL,
respectively. The flow rates of the group II were 2.0 mL/hr,
1.7 mL/hr, and 2.4 mL/hr during the corresponding delivery
periods (Table 1). The actual flow rate was plotted against
the infusor volume. The flow rate was significantly higher
in the early phase and the late phase of the drug delivery than
in the intermediate delivery phase (Fig. 4, 5). The instabili-
ty of the flow rates during the early and late phases of the
delivery was also observed in both kinds of infusors. The
variability of the flow rates among 15 products was also
increased during the early and late phases. The group I
showed the lowest flow rate in the about 50-60 mL of the
infusor volume and the group II showed a decreasing ten-
dency of the flow rates during the intermediate delivery
phase (80-10 mL).
DISCUSSION
The two balloon elastomeric infusion devices used in this
study are based on the same principle, although they have
different shapes and are composed of different materials. It
consists of a drug reservoir, outer housing, non-kinking deliv-
ery tube, filter that removes bacteria and air bubbles, and
Luer body that houses a size-controlled orifice or filament
and acts as a valve responsible for the maintenance of the
preset flow rate and filling port through which the drug is
filled into the reservoir. The balloon reservoir serves a sus-
tained internal pressure as a driving force and the Luer body
makes a resistance as a flow control device. So, the flow rate
of these devices is determined by the constant pressure in the
elastomeric membrane of the reservoir coupled with various
flow control devices (13). Usually, these devices are recom-
mended to use at room temperature (below 38℃), and in
some products the flow rate in the state the Luer body con-
tacts with the patient’ s skin is illustrated. This may be due
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Fig. 3. Internal pressure-infusor volume curve in the elastomeric
balloon infusor. The monitored internal pressure of the infusor
decreased, was maintained, and increased according to the
infusor volume.
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Fig. 4. Flow rate versus infusor volume curve in the Advance Sili-
cone Infusor.
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Fig. 5. Flow rate versus reservoir infusor volume curve in the
Baxter Twoday Infusor.
*: p<0.05 compared to the 100-80 mL range, 
� : p<0.05 compared to
the 80-10 mL range, 
� : p<0.05 compared to the 10-0 mL range by one-
way repeated measures ANOVA.
Volume of the infusor
100-80 (mL) 80-10 (mL) 10-0 (mL)
Advance Silicone Infusor (mL/hr) 1.9
� ,� ±0.2 1.6*
,� ±0.1 2.2*
,� ±0.2
Baxter Twoday Infusor (mL/hr)     2.0
� ,� ±0.3 1.7*
,� ±0.3 2.4*
,� ±0.5
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to the expansion or constriction of the reservoir or Luer body
by the change of the temperature. We tried to conduct the
experiments at a constant room temperature, but there was
a room for a small change in temperature. In the practical
use, the devices are used at room temperature, and we could
apply our results to the clinical settings. At a relatively con-
stant room temperature, if the internal diameter of the Luer
body does not change, the internal pressure of the infusor
will decide the flow rate of the elastomeric balloon infusor. 
The driving force in the elastomeric balloon infusor is the
elasticity of the material, which has been already determined
in the process of sulfuration or bridging process in the rub-
ber or silicone (14, 15). The internal pressure in the group
II was higher than that in the group I. This may be due to
the larger stress caused by the larger strain in the rubber than
in the silicone. Theoretically, the internal pressure of the infu-
sor must be maintained uniformly up to the preset reservoir
volume limit. However, in this study, the internal pressure
of the infusor varied with the elapse of the delivery time.
Some factors might have influenced this pressure pattern.
The strain might increase owing to the abrupt increase of
volume when the reservoir was filled with normal saline
100 mL, resulting in the increase of the internal pressure.
During the intermediate delivery phase, the internal pressure
was sustained at a somewhat decreased level for the uniform
elasticity of the material. Then, the internal pressure distinct-
ly increased again by the effect of increased depth itself of the
material when the infusor volume outstandingly decreased.
The depth of the material could increase because of the de-
creased surface area during the delivery of drug. We think
that it is important to maintain the ratio of the surface area
to the volume during the drug delivery and that it is neces-
sary to have a concern about this problem in the develop-
ment of the shape of the balloon infusor. The decrease in the
internal pressure of the infusor might be observed for the
decreased membrane stress in the thin-walled pressure ves-
sel shape caused by the decreased internal force, radius, and
increased depth during the delivery ( ∝P∙r/t, :  mem-
brane stress, P: internal force, r: radius, t: depth of mem-
brane) (16, 17). This can be compensated by the elasticity
in the elastomeric balloon infusor. Coley et al. showed that
the mean flow rate of the balloon infusors during the first
two hours was significantly higher than during the last two
hours (10), but they could not observe the increased flow
rate during the final period because they limited the dura-
tion of the study. Veal et al. reported the residual volume of
the infusor at the end of delivery in the study about the flow
rates of the infusors, however, they also restricted the obser-
vation period (12) and did not investigate further. Mackey
et al. observed that as the infusor became exhausted, the
delivery increased to a maximum value, ranging from 118%
to 137% of normal, before falling to zero (18). In a clinical
situation, it may be important to know the increased flow
rate during the terminal phase of the delivery, because it cor-
responds to the decreased analgesic demand of the patients.
The studies about the flow rate of elastomeric balloon infu-
sor have shown common results of the unstable and rela-
tively high flow rates during the early infusion period (13,
18). This might be explained by the process of stabilization
after relaxation of the high molecular strain in rubber or sil-
icone due to the acutely increased infusor volume (14). The
group II tended to have a somewhat decreased flow rate dur-
ing the intermediate phase. This might be partly explained
by the change of the elasticity of the material with the elapse
of the infusion time. Thus, it is important to sustain the
elasticity during the total infusion period in the use of over
48 hr. 
Many factors can influence the flow rate, such as environ-
mental temperature, fluid viscosity, and type of the venous
access (18, 19). However, the intent of this study was to ex-
amine the change of the driving force and flow rates accord-
ing to the volume of the infusor. Conclusively, in applying
the elastomeric balloon infusor to the patients, we must keep
the fact in mind that the balloon infusors do not provide
uniform drug delivery.
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